Annual Interest Expense
$75.00 K
+$61.00 K+435.71%
31 December 2023
Summary:
Seelos Therapeutics annual interest expense is currently $75.00 thousand, with the most recent change of +$61.00 thousand (+435.71%) on 31 December 2023. During the last 3 years, it has fallen by -$89.00 thousand (-54.27%). SEEL annual interest expense is now -99.74% below its all-time high of $28.70 million, reached on 31 December 2009.SEEL Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$23.00 K
$0.000.00%
30 June 2024
Summary:
Seelos Therapeutics quarterly interest expense is currently $23.00 thousand, unchanged on 30 June 2024. Over the past year, it has dropped by -$19.00 thousand (-45.24%). SEEL quarterly interest expense is now -99.92% below its all-time high of $28.21 million, reached on 31 December 2009.SEEL Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$107.00 K
+$16.00 K+17.58%
30 June 2024
Summary:
Seelos Therapeutics TTM interest expense is currently $107.00 thousand, with the most recent change of +$16.00 thousand (+17.58%) on 30 June 2024. Over the past year, it has increased by +$51.00 thousand (+91.07%). SEEL TTM interest expense is now -99.70% below its all-time high of $35.59 million, reached on 31 March 2010.SEEL TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SEEL Interest Expense Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +435.7% | -45.2% | +91.1% |
3 y3 years | -54.3% | +15.0% | -93.9% |
5 y5 years | +100.0% | +2200.0% | +225.9% |
SEEL Interest Expense High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -95.3% | +435.7% | -45.2% | -93.9% | +664.3% | |
5 y | 5 years | -95.3% | -97.7% | -93.9% | +225.9% | ||
alltime | all time | -99.7% | -99.9% | +120.3% | -99.7% | +225.9% |
Seelos Therapeutics Interest Expense History
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2024 | - | $23.00 K(0.0%) | $107.00 K(+17.6%) |
Mar 2024 | - | $23.00 K(+21.1%) | $91.00 K(+21.3%) |
Dec 2023 | $75.00 K(+435.7%) | $19.00 K(-54.8%) | $75.00 K(+33.9%) |
Sept 2023 | - | $42.00 K(+500.0%) | $56.00 K(+250.0%) |
June 2023 | - | $7000.00(0.0%) | $16.00 K(+14.3%) |
Mar 2023 | - | $7000.00(>+9900.0%) | $14.00 K(0.0%) |
Dec 2022 | $14.00 K(-99.1%) | $0.00(-100.0%) | $14.00 K(-26.3%) |
Sept 2022 | - | $2000.00(-60.0%) | $19.00 K(-48.6%) |
June 2022 | - | $5000.00(-28.6%) | $37.00 K(-94.0%) |
Mar 2022 | - | $7000.00(+40.0%) | $615.00 K(-61.5%) |
Dec 2021 | $1.60 M(+874.4%) | $5000.00(-75.0%) | $1.60 M(-8.4%) |
Sept 2021 | - | $20.00 K(-96.6%) | $1.74 M(+0.8%) |
June 2021 | - | $583.00 K(-41.1%) | $1.73 M(+50.4%) |
Mar 2021 | - | $990.00 K(+555.6%) | $1.15 M(+601.2%) |
Dec 2020 | $164.00 K(+465.5%) | $151.00 K(+2416.7%) | $164.00 K(+1071.4%) |
Sept 2020 | - | $6000.00(+100.0%) | $14.00 K(+55.6%) |
June 2020 | - | $3000.00(-25.0%) | $9000.00(-47.1%) |
Mar 2020 | - | $4000.00(+300.0%) | $17.00 K(-41.4%) |
Dec 2019 | $29.00 K(>+9900.0%) | $1000.00(0.0%) | $29.00 K(-134.1%) |
Sept 2019 | - | $1000.00(-90.9%) | -$85.00 K(+347.4%) |
June 2019 | - | $11.00 K(-31.3%) | -$19.00 K(-36.7%) |
Mar 2019 | - | $16.00 K(-114.2%) | -$30.00 K(-34.8%) |
Dec 2018 | $0.00(-100.0%) | -$113.00 K(-268.7%) | -$46.00 K(-175.4%) |
Sept 2018 | - | $67.00 K(>+9900.0%) | $61.00 K(-608.3%) |
Mar 2018 | - | $0.00(-100.0%) | -$12.00 K(-114.5%) |
Dec 2017 | $83.00 K(-91.6%) | -$6000.00(+100.0%) | $83.00 K(-72.4%) |
Sept 2017 | - | -$3000.00(0.0%) | $301.00 K(-44.1%) |
June 2017 | - | -$3000.00(-103.2%) | $538.00 K(-32.7%) |
Mar 2017 | - | $95.00 K(-55.2%) | $799.00 K(-18.7%) |
Dec 2016 | $983.00 K | $212.00 K(-9.4%) | $983.00 K(-8.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2016 | - | $234.00 K(-9.3%) | $1.07 M(-3.0%) |
June 2016 | - | $258.00 K(-7.5%) | $1.10 M(+8.7%) |
Mar 2016 | - | $279.00 K(-7.3%) | $1.02 M(+13.5%) |
Dec 2015 | $895.00 K(+164.0%) | $301.00 K(+12.7%) | $896.00 K(+25.5%) |
Sept 2015 | - | $267.00 K(+57.1%) | $714.00 K(+45.4%) |
June 2015 | - | $170.00 K(+7.6%) | $491.00 K(+25.9%) |
Mar 2015 | - | $158.00 K(+32.8%) | $390.00 K(+15.0%) |
Dec 2014 | $339.00 K(-53.4%) | $119.00 K(+170.5%) | $339.00 K(+3.0%) |
Sept 2014 | - | $44.00 K(-36.2%) | $329.00 K(-28.3%) |
June 2014 | - | $69.00 K(-35.5%) | $459.00 K(-23.9%) |
Mar 2014 | - | $107.00 K(-1.8%) | $603.00 K(-17.1%) |
Dec 2013 | $727.00 K(+123.7%) | $109.00 K(-37.4%) | $727.00 K(-0.1%) |
Sept 2013 | - | $174.00 K(-18.3%) | $728.00 K(+16.1%) |
June 2013 | - | $213.00 K(-7.8%) | $627.00 K(+29.0%) |
Mar 2013 | - | $231.00 K(+110.0%) | $486.00 K(+49.1%) |
Dec 2012 | $325.00 K(-10.7%) | $110.00 K(+50.7%) | $326.00 K(+50.9%) |
Sept 2012 | - | $73.00 K(+1.4%) | $216.00 K(+51.0%) |
June 2012 | - | $72.00 K(+1.4%) | $143.00 K(-8.5%) |
Mar 2012 | - | $71.00 K(-16.8%) | $156.30 K(-63.5%) |
Dec 2011 | $364.00 K(-95.9%) | - | - |
June 2011 | - | $85.30 K(-23.1%) | $428.50 K(+24.9%) |
Mar 2011 | - | $110.90 K(+54.7%) | $343.20 K(-95.2%) |
Dec 2010 | $8.82 M(-69.3%) | $71.70 K(-55.4%) | $7.21 M(-79.6%) |
Sept 2010 | - | $160.60 K(-97.7%) | $35.35 M(-0.7%) |
Mar 2010 | - | $6.98 M(-75.3%) | $35.59 M(+24.0%) |
Dec 2009 | $28.70 M(+2750.2%) | $28.21 M(>+9900.0%) | $28.70 M(+5849.8%) |
Sept 2009 | - | $276.20 K(+134.9%) | $482.30 K(+134.0%) |
June 2009 | - | $117.60 K(+32.9%) | $206.10 K(-67.1%) |
Mar 2009 | - | $88.50 K(-83.6%) | $627.10 K(+16.4%) |
Dec 2008 | $1.01 M | - | - |
June 2008 | - | $538.60 K | $538.60 K |
FAQ
- What is Seelos Therapeutics annual interest expense?
- What is the all time high annual interest expense for Seelos Therapeutics?
- What is Seelos Therapeutics annual interest expense year-on-year change?
- What is Seelos Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Seelos Therapeutics?
- What is Seelos Therapeutics quarterly interest expense year-on-year change?
- What is Seelos Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Seelos Therapeutics?
- What is Seelos Therapeutics TTM interest expense year-on-year change?
What is Seelos Therapeutics annual interest expense?
The current annual interest expense of SEEL is $75.00 K
What is the all time high annual interest expense for Seelos Therapeutics?
Seelos Therapeutics all-time high annual interest expense is $28.70 M
What is Seelos Therapeutics annual interest expense year-on-year change?
Over the past year, SEEL annual interest expense has changed by +$61.00 K (+435.71%)
What is Seelos Therapeutics quarterly interest expense?
The current quarterly interest expense of SEEL is $23.00 K
What is the all time high quarterly interest expense for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly interest expense is $28.21 M
What is Seelos Therapeutics quarterly interest expense year-on-year change?
Over the past year, SEEL quarterly interest expense has changed by -$19.00 K (-45.24%)
What is Seelos Therapeutics TTM interest expense?
The current TTM interest expense of SEEL is $107.00 K
What is the all time high TTM interest expense for Seelos Therapeutics?
Seelos Therapeutics all-time high TTM interest expense is $35.59 M
What is Seelos Therapeutics TTM interest expense year-on-year change?
Over the past year, SEEL TTM interest expense has changed by +$51.00 K (+91.07%)